GREAT LAKES BAY VENTURE — 2015 Investments
1 investments dated 2015 · listed companies and verified rows first · show all
RetroSense TherapeuticsAug 2015acquired by AllerganSEC filingmedium confidence
First-in-class optogenetic therapy for retinal diseases; acquired by Allergan.
BiotechAnn Arbor, US
Terry Cross(Director)Cam Gallagher(Director)Sean Ainsworth(Executive Officer, Director)George Lasezkay(Director)Kenneth Kousky(Director)
Board seatKenneth Kousky· per SEC Form D · $5M raise · filed Oct 2015
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.